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Abstract
Objective:  The  purpose  of  the  current  study  was  to  assess  changes  in  human  corneal  rigidity
after treatment  with  riboﬂavin  and  UVA  using  a  new  device,  the  Corneal  Displacement  Unit
(CDU).
Design: Experimental  study.  The  CDU  was  designed  to  quantitatively  measure  the  effect  of
cross-linking  (CXL)  in  complete  human  donor  cornea  buttons.  This  apparatus  measures  the  tissue
displacement  associated  to  computer-controlled  variations  in  pressure.
Methods:  Baseline  measurements  with  the  CDU  were  taken  from  10  de-epithelialized  human
corneas. They  were  exposed  to  0.1%  riboﬂavin  drops  every  2  min  for  1  h  with  exposure  to  UVA
light during  the  last  30  min  after  which  CDU  measurements  were  taken  again.  Results  were
analyzed  using  a  non-parametric  test.  Signiﬁcant  tests  were  set  at  P  ≤  .15  and  non-signiﬁcant
correlation  coefﬁcients  at  rho  ≤  .15  to  reject  abnormal  measurements.  For  each  of  the  10
corneas, pachymetry  values  and  1988  CDU  measurements  were  collected  before  and  after
treatment.
Results: Pressure  measurements  averaged  across  the  corneas  were  similar  before  and  after
treatment  (P  ≥  .99),  and  were  highly  correlated  (Spearman  rho  =  .88,  P  <  .001).  Corneal  dis-
placement  observations  after  treatment  were  signiﬁcantly  different  from  baseline,  showing  a
reduction  of  .084  microns  on  average  (P  <  .001),  and  thus  demonstrating  a  reduced  displacement
in cross-linked  corneas.∗ Corresponding author at: Hospital Ángeles de las Lomas, Consultorio 735, Vialidad de la Barranca s/n, Col Valle de las Palmas, Huixquilu-
an, Estado de México CP 52763, Mexico. Tel.: +52 46 9809; fax: +52 46 9808.
E-mail address: drlichtinger@yahoo.com (A. Lichtinger).
ttp://dx.doi.org/10.1016/j.mexoft.2015.08.009
187-4519/© 2015 Sociedad Mexicana de Oftalmología. Published by Masson Doyma México S.A. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Ex  vivo  human  cornea  rigidity  after  UVA/riboﬂavin  induced  cross-linking  231
Conclusions:  The  present  study  demonstrated  a  signiﬁcant  increase  in  the  mechanical  rigidity
of human  corneas  after  CXL.  The  CDU  was  able  to  quantify  the  mechanical  strength  of  whole
corneal buttons  ex  vivo  with  minimal  damage  to  the  tissue.
© 2015  Sociedad  Mexicana  de  Oftalmología.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Cambios  inducidos  por  cross-linking  con  UVA/riboﬂavina  en  la  rigidez  corneal  ex  vivo
Resumen
Objetivo:  El  objetivo  de  este  estudio  fue  estudiar  los  cambios  en  la  rigidez  corneal  tras  el
tratamiento  con  Riboﬂavina  y  luz  ultravioleta  (UVA)  utilizando  un  nuevo  aparato,  la  unidad  de
desplazamiento  corneal  (CDU).
Disen˜o:  Estudio  experimental.  El  CDU  fue  disen˜ando  para  medir  cuantitativamente  el  efecto
del cross-linking  (CXL)  en  botones  corneales  humanos.  El  instrumento  mide  el  desplazamiento
asociado  a  variaciones  en  la  presión  controladas  por  computadora.
Métodos:  Tomamos  medidas  basales  con  el  CDU  en  10  corneas  tras  remover  el  epitelio.  Las
corneas fueron  expuestas  a  Riboﬂavina  0.1%,  1  gota  cada  2  minutos  durante  1  hora  con
exposición a  UVA  durante  los  últimos  30  minutos,  al  ﬁnalizar  se  tomaron  mediciones  con  el
CDU nuevamente.  los  resultados  fueron  analizados  con  prueba  no  paramétrica.,  La  validez  se
estableció con  P  ≤  .15  y  el  coeﬁciente  de  correlación  no  signiﬁcativo  en  rho  ≤  .15  para  descar-
tar mediciones  anormales.  Para  cada  cornea,  valores  paquimétricos  y  1988  mediciones  del  CDU
fueron tomadas  antes  y  después  del  CXL.
Resultados:  Los  valores  promedio  de  presión  entre  las  corneas  fueron  similares  antes  y  después
del tratamiento.  (P  ≥  0.99),  con  una  alta  congruencia  (Spearman  rho  =  0.88,  P  <  0.001)  a  difer-
encia de  las  mediciones  de  desplazamiento,  donde  los  valores  después  de  CXL  mostraron  una
reducción  promedio  de  0.084  micras  (P  <  .001);  demostrando  así  un  desplazamiento  reducido
en las  corneas  tratadas.
Conclusiones:  Este  estudio  demuestra  un  aumento  en  la  rigidez  corneal  tras  tratamiento  con
CXL. El  CDU  logro  cuantiﬁcar  el  endurecimiento  de  botones  corneales  ex  vivo  con  dan˜o  mínimo
al tejido.
©  2015  Sociedad  Mexicana  de  Oftalmología.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Materials and methodsIntroduction
Corneal  cross-linking  (CXL)  is  a  novel  approach  to  strengthen
the  cornea  by  increasing  the  mechanical  and  biochemical
stability  of  stromal  tissue.  CXL  consists  in  photopolymer-
ization  of  stromal  ﬁbers  by  the  combined  actions  of  a
photosensitizing  agent  (riboﬂavin)  and  Ultraviolet-A  (UVA),
which  leads  to  an  increase  in  the  collagen  ﬁber  diameter
and  corneal  stiffness.1,2
Biomechanical  properties  of  the  cornea  have  been  widely
studied  as  a  way  of  addressing  corneal  changes  after  CXL,
providing  crucial  information  to  understand  the  fundamen-
tals  of  this  treatment.  Wollensak  and  coworkers3 analyzed
corneal  rigidity  by  stress-strain  measurements  of  corneal
strips  on  a  microcomputer-controlled  biomaterial  tester.
They  found  an  increase  in  rigidity,  indicated  by  rise  in  stress,
of  more  than  300%  in  treated  human  corneas.  Later,  Kohlhaas
4et  al. used  corneal  biomechanical  properties  to  describe
the  localized  effect  of  CXL  in  the  anterior  portion  of  strips
of  human  and  porcine  corneas.
T
dUntil  recently,  the  study  of  tissue  mechanical  properties
as  relied  on  methods  such  as  tensile  tests,  which  require
he  samples  to  be  cut.  To  better  ascertain  the  effects  of  the
XL  process,  it  is  necessary  to  utilize  techniques  that  are
apable  of  evaluating  biomechanical  properties  within  com-
lete  corneas.  The  aim  of  the  present  study  was  to  assess
hanges  in  human  corneal  rigidity  after  treatment  with
iboﬂavin  and  UVA  irradiation.  For  this  purpose  we  designed
 new  device,  the  Corneal  Displacement  Unit  (CDU),  to  quan-
itatively  measure  the  effect  of  CXL  in  complete  human
onor  cornea  buttons.  This  apparatus  measures  the  tissue
isplacement  associated  to  computer-controlled  variations
n  pressure.  Results  obtained  from  this  study  may  further
xpand  our  understanding  of  CXL  process  and  its  potential
ole  in  our  therapeutic  armamentarium.he  CDU  was  designed  with  the  help  of  the  bioengineering
epartment  at  our  university;  once  the  ﬁnal  model  was  built,
2 A.  Lichtinger  et  al.
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Figure  1  Corneal  Displacement  Unit:  a  computer  regulated
piezo-electric  pressure  transducer  is  connected  to  an  artiﬁcial
anterior  chamber  via  semi-rigid  surgical  tubing  ﬁlled  with  bal-
anced salt  solution.  This  system  allowed  for  precise  computer
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everal  test  runs  with  human  corneal  buttons  demonstrated
tability  of  the  measurements;  corneas  without  exposure
o  riboﬂavin  or  UVA  light  were  maintained  in  the  artiﬁcial
hamber  and  measurements  repeated  twice  during  the  next
our,  these  preliminary  data  taught  us  that  as  long  as  we
ept  a  stable  pachymetry  throughout  the  experiment  the
isplacement  remained  steady.  Taking  this  into  consider-
tion  we  designed  the  present  study  to  assess  the  effect
f  CXL  in  corneal  displacement  with  the  CDU.
Ten  research  grade  corneas  not  suitable  for  corneal  trans-
lantation  were  obtained  from  the  San  Diego  Eye  Bank.  The
ost-mortem  time  of  the  human  eyes  was  less  than  48  h.
orneas  that  had  prior  surgery,  scarring  or  pathology  that
ould  affect  corneal  clarity  or  hydration  were  not  accepted
or  the  study.
We  removed  the  corneal  epithelium  from  10  corneas,
ook  baseline  measurements  with  the  CDU,  and  then
xposed  the  corneas  to  0.1%  isotonic  riboﬂavin  drops  (10  mg
iboﬂavin-5-phosphate  in  10  ml  dextran  T-500  20%)  every
 min  for  1 h  with  exposure  to  UVA  light  during  the  last  30  min
fter  which  CDU  measurements  were  taken  again.
Pachymetry  measurements  were  performed  in  all  corneas
mmediately  after  removal  of  the  epithelium,  before  UVA
xposure  and  before  the  second  CDU  measurement  to  ensure
 stable  pachymetry  between  readings  (±40  m).
VA  irradiation
VA  exposure  was  performed  with  a  Vega  LED-based  UV
mitter  (CSO  Srl.  Firenze,  Italy)  assembled  and  tested
ccording  to  the  manufacturers  instructions.  The  Vega  LED
s  preset  to  emit  radiation  of  370  nm  wavelength  at  an  inten-
ity  of  3.0  mW/cm2;  a  UV  meter  was  used  to  check  the  UV
mission  power  at  the  treatment  plane  before  exposure.
xposure  was  carried  out  for  30  min  with  a  10  mm  treatment
iameter  as  per  the  manufacturer’s  protocol.
orneal  Displacement  Unit
he  CDU  consists  of  a  computer  regulated  piezo-electric
ressure  transducer  that  is  connected  to  an  artiﬁcial  ante-
ior  chamber  via  semi-rigid  surgical  tubing  ﬁlled  with
alanced  salt  solution  (Fig.  1).  Ex  vivo  human  corneal  tis-
ue  was  then  mounted  onto  the  artiﬁcial  anterior  chamber
nd  a  watertight  seal  was  obtained.  This  system  allowed  for
recise  computer  control  of  the  internal  pressure  within  the
rtiﬁcial  anterior  chamber  using  LabView  (National  Instru-
ents  Corporation,  Austin,  TX).
A  HeNe  laser  emitter  and  solid-state  detector  unit  with
xed  placement  were  both  mounted  above  the  apex  of  the
orneal  tissue.  After  internal  calibration  of  the  laser,  the
issue  was  placed  at  an  appropriate  distance  from  the  laser
uch  that  the  reﬂected  beam  was  within  the  detectors  range
o  allow  for  measurements  of  the  physical  displacement  of
he  corneal  apex.  These  measurements  were  obtained  using
abView  and  were  correlated  with  the  corresponding  pres-
ure  applied  by  the  pressure  transducer  within  the  artiﬁcial
nterior  chamber.  We  placed  the  corneas  in  pressure  cycles
hat  range  from  0.1  to  1.0  PSI,  which  corresponds  to  an  intra-
cular  pressure  of  5.6  mmHg  to  56  mmHg,  with  a  frequency
f  6  cycles  per  minute  for  10  min.
s
p
t
tontrol  of  the  internal  pressure  within  the  artiﬁcial  ante-
ior chamber  using  LabView  (National  Instruments  Corporation,
ustin,  TX).
We  performed  preliminary  testing  in  5  corneas  which
ere  placed  in  the  CDU  for  a  full  hour  without  the  CXL
rocedure;  these  corneas  showed  pressure  and  corneal  dis-
lacement  measurements  that  were  stable  throughout  the
imeline  validating  the  accuracy  and  baseline  measurements
or  our  study.  In  this  study  we  compared  pretreatment  and
ost-CXL  CDU  measurements  in  each  cornea  tested.
tatistical  analysis
or  each  of  the  10  corneas,  pachymetry  values  and  1988
DU  measurements  were  collected  before  and  after  treat-
ent.  Stability  of  measurements  before  and  after  treatment
as  examined  for  each  cornea  using  non-parametric  tests,
.e.,  Wilcoxon  matched  pairs  test,  and  Spearman  correla-
ion.  Signiﬁcant  tests  were  set  at  P  ≤  .15  and  non-signiﬁcant
orrelation  coefﬁcients  at  rho  ≤  .15  to  reject  abnormal  mea-
urements.  All  measurements  were  then  averaged  across
ll  corneas  retained  for  analysis  and  analyzed  using  non-
arametric  tests  to  assess  any  change  in  displacement
ost-CXL  treatment  from  preoperative  CDU  measurements.
esults
e  were  able  to  perform  all  the  measurements  in  9  out  of  10
orneas;  results  from  corneal  button  #  1  were  discarded  due
o  abnormal  values  caused  by  a  leak  from  the  artiﬁcial  ante-
ior  chamber.  This  leak  was  likely  caused  by  a  small  diameter
cleral  ring.  Another  2  corneal  button  measurements  were
iscarded  after  statistical  analysis  due  to  skewed  observa-
ions  between  the  data  collected  before  and  after  CXL.  The
omputer  captured  too  many  data  points  at  the  highest  pres-
ure  values  on  the  untreated  corneal  buttons  and  too  many
oints  at  the  lowest  pressure  values  once  the  corneal  but-
ons  were  CXL;  these  data  had  a  correlation  near  to  0  and
herefore  could  not  be  utilized  in  our  study.
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Table  1  Mean  (SD),  median  (range)  measurements  of  IOP  in  PSI  for  10  human  corneas  before  and  after  CXL  treatment.
Cornea  Before  CXL  After  CXL  P  values*
1. Mean  (SD)  .625  (.270)  .335  (.270)
<.001
Median  (range)  .660  (.09--1.0)  .199  (1.0--1.0)
Skewness  −0.330  1.169
Kurtosis  −1.135  −0.053
2. Mean (SD)  .622  (.268)  .623  (.270)
0.867
Median  (range)  .660  (.06--1.0)  .660  (.02--1.0)
Skewness  −0.310 −.336
Kurtosis −1.144 −1.134
3. Mean  (SD) .623  (.269) .625  (.269)
0.599
Median  (range) .660  (.06--1.0) .660  (.08--1.0)
Skewness  −0.321  −.331
Kurtosis  −1.137  −1.133
4. Mean (SD)  .624  (.270)  .625  (.273)
0.859
Median  (range)  .660  (.06--1.0)  .670  (.06--1.0)
Skewness  −0.340  −.344
Kurtosis  −1.130  −1.149
5. Mean (SD)  .624  (.271)  .624  (.273)
0.396
Median  (range)  .670  (.10--1.0)  .680  (.09--1.0)
Skewness  −0.341  −.349
Kurtosis  −1.144  −1.169
6. Mean (SD)  .624  (.270)  .721  (.296)
<.001
Median  (range)  .660  (.08--1.0)  .790  (.07--1.1)
Skewness  −0.326  −.547
Kurtosis  −1.141  −0.987
7. Mean (SD)  .625  (.269)  .623  (.269)
0.947
Median  (range)  .660  (.02--1.0)  .660  (.05--1.1)
Skewness  −0.328  −.336
Kurtosis  −1.136  −1.128
8. Mean (SD)  .622  (.267)  .621  (.270)
0.872
Median  (range)  .660  (.05--1.0)  .660  (.10--1.0)
Skewness  −0.318  −.318
Kurtosis  −1.138  −1.157
9. Mean (SD)  .609  (.303)  .552  (.290)
<.001
Median  (range)  .650  (.08--1.0)  .550  (.10--1.0)
Skewness  −0.213  −.023
Kurtosis  −1.403  −1.408
10. 10 Mean  (SD)  .619  (.268)  .625  (.267)
0.456
Median  (range)  .650  (.06--1.0)  .660  (.10--1.0)
Skewness  −0.285  −.330
Kurtosis  −1.161  −1.145
D
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m* Wilcoxon matched pairs test.
Tables  1  and  2,  respectively,  show  IOP  and  corneal  dis-
placement  measurements  for  10  human  corneas  before
and  after  CXL  treatment.  Pressure  measurements  averaged
across  the  7  remaining  corneas  were  similar  before  and  after
treatment  (P  ≥  .99),  and  were  highly  correlated  (Spear-
man  rho  =  .88,  P  <  .001).  Corneal  displacement  observations
after  treatment  were  signiﬁcantly  different  from  baseline,
showing  a  reduction  of  .084  m  on  average  (P  <  .001),  and
thus  demonstrating  a  reduced  displacement  in  cross-linked
corneas  (Table  3,  Fig.  2).
t
c
iiscussion
n  the  current  study,  we  demonstrated  an  increase  in
echanical  stability  by  the  reduction  on  corneal  displace-
ent  of  ex  vivo  human  corneas  after  treatment  with
iboﬂavin  and  UVA.  The  CDU  provides  reproducible  displace-
ent  values  of  the  cornea  with  minimal  damage  to  theissue.  This  new  technique  may  potentially  validate  and
ompare  new  treatment  strategies  by  evaluating  changes
n  corneal  stiffness  caused  by  CXL.
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Table  2  Mean  (SD),  median  (range)  for  corneal  displacement  measurements  in  microns  for  10  human  corneas  before  and  after
CXL treatment.
Cornea  Before  CXL  After  CXL  Mean  difference  P  values*
1.E Mean  (SD) .111  (.003)  .093  (.002)  −.018  (.003)
<.001Median (range)  .112  (.082--0.114)  .199  (.076--.095)
2. Mean  (SD)  .099  (.002)  .107  (.003)  .008  (.003)
<.001Median (range)  .098  (.098--.110)  .106  (.105--.118)
3. Mean  (SD)  .078  (.003)  .073  (.001)  −.005  (.003)
<.001Median (range)  .079  (.068--.082)  .073  (.064--.075)
4. Mean  (SD)  .117  (.001)  .092  (.012)  −.025  (.012)
<.001Median (range) .118  (.115--.123)  .073  (.071--.125)
5. Mean  (SD) .116  (.002)  .092  (.001)  −.026  (.002)
<.001Median (range) .116  (.102--.119) .091  (.088--.095)
6.E Mean  (SD)  .107  (.002)  .104  (.001)  −.003  (.002)
<.001Median (range)  .107  (.095--.120)  .103  (.101--.106)
7. Mean  (SD)  .108  (.003)  .053  (.001)  −.055  (.003)
<.001Median (range)  .107  (.105--.123)  .053  (.051--.055)
8. Mean  (SD)  .067  (.002)  .082  (.001)  .015  (.001)
<.001Median (range)  .067  (.061--.071)  .082  (.082--.086)
9.E Mean  (SD)  .109  (.002)  .109  (.001)  −.001  (.002)
.250Median (range)  .109  (.107--.122)  .109  (.108--.110)
10. Mean  (SD)  .121  (.001)  .122  (.001)  .001  (.001)
<.001Median (range)  .121  (.117--.124)  .122  (.120--125)
* Wilcoxon matched pairs test.
E Excluded from ﬁnal analysis due to unstable IOP measurements.
Table  3  IOP  and  corneal  displacement  measurements  averaged  across  the  7  remaining  corneas  before  and  after  CXL  treatment.
Cornea  Before  CXL  After  CXL  Mean  difference  P  values*
IOP
Mean  (SD) 4.36  (1.60)  4.37  (1.32)  .01  (.80)
.99Median  (range) 4.54  (.59--6.72) 4.49  (.68--4.92)  .05  (.09--1.80)
Displacement
Mean (SD)  .706  (.007)  .622  (.014)  −.084  (.014)
<.001Median (range)  .704  (.684--.732)  .615  (.597--.664)  −.09  (.87--.68)
* Wilcoxon matched pairs test.
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maintain  constant  pressure  behind  the  cornea  during  theFigure  2  Corneal  Displacement  before  and  after  CXL.
CXL  has  emerged  as  a  promising  alternative  to  intra-
tromal  implants,  penetrating  or  lamellar  keratoplasty  in
he  treatment  of  keratoconus  and  post-refractive  ectasia.5--7
herefore,  new  technologies  to  assess  the  effects  of  CXL  are
eeded.  The  majority  of  experimental  studies3,4,8 used  ten-
ile  measurements  in  order  to  assess  stress--strain  properties
fter  CXL.  Although  these  techniques  provide  important
t
m
miomechanical  data,  they  require  the  cornea  to  be  sec-
ioned,  which  alters  the  properties  of  the  corneal  button
unctioning  as  an  entire  unit.  Some  of  these  experimental
roblems  include  the  following:  the  collagen  ﬁbers  at  the
dge  of  these  sliced  samples  are  fragmented,  thus  reducing
he  predictability  of  the  measurements;  the  segmentation  of
he  corneal  buttons  leaves  them  susceptible  to  changes  in
ydration  that  can  further  modify  the  biomechanical  proper-
ies  of  the  tissue.  Furthermore,  because  these  samples  must
e  clamped  in  the  jaws  of  the  device,  the  edges  are  submit-
ed  to  compressive  tension  that  may  alter  the  ﬁnal  results.
n  contrast,  the  CDU,  used  in  the  present  study,  allows  us  to
nalyze  the  response  of  the  whole  cornea  as  a unit.  There
s  no  need  for  segmenting  the  tissue  since  the  whole  but-
on  is  mounted  on  the  artiﬁcial  chamber  where  it  stays  in
lace  during  the  whole  experiment.  This  also  allows  us  toime  between  measurements.  Characteristics  of  this  CDU
ay  optimize  biomechanical  measurements  and  serve  as  a
odel  for  further  applications.
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1Ex  vivo  human  cornea  rigidity  after  UVA/riboﬂavin  induced  c
Corneal  biomechanical  analysis  has  enhanced  our  under-
standing  of  the  CXL  process.  In  2003,  Wollensak3 ﬁrst
described  the  results  of  mechanical  measurements  of  human
corneal  strips  after  CXL.  An  increase  in  rigidity  of  328.9%  was
observed  after  treatment,  with  a  corresponding  increase
of  4.5  in  Young’s  modulus.  The  same  biomaterial  measur-
ing  device  was  used  by  Kohlhaaset  et  al.4 to  evaluate  stress
strain  characteristics  of  the  anterior  and  posterior  portions
of  the  cornea.  Their  results  provided  further  evidence  that
the  effect  of  CXL  is  greater  in  the  anterior  stroma.9--13
Recently,  this  type  of  measurements  was  also  used  to  eval-
uate  the  CXL  effect  after  modiﬁcations  of  the  standard  CXL
technique.  Rigidity  analysis  was  used  to  compare  CXL  effects
on  corneas  with  and  without  de-epithelialization14 and  it
was  demonstrated  that  corneas  with  intact  epithelium  had  a
decreased  stiffening  effect.  Similar  studies  were  performed
by  McCall  et  al.,8 but  in  all  of  these  studies,  and  in  contradis-
tinction  with  the  CDU  described  in  the  present  manuscript,
cutting  the  corneas  into  segments  was  necessary  to  allow
for  the  measurement  of  biomechanical  data.
The  need  for  a  non-destructive  technique  to  assess
corneal  stiffness  and  biomechanical  properties  is  soaring;
therefore  other  investigators,  including  Duppset  et  al.15
and  Mattson  et  al.16 have  explored  other  potential  tech-
niques  that  may  allow  the  analysis  of  corneal  rigidity  in
whole  corneal  buttons.  A  technique  named  Globe  Expansion
Method  (GEM)16 was  tested  in  rabbit  eyes  with  the  purpose
of  measuring  the  behavior  of  cross-linked  tissue  to  elevated
intra-ocular  pressure;  in  this  study,  corneas  submitted  to
riboﬂavin  and  UVA  had  a  reduced  expansion  compared  with
control  corneas.  Another  non-invasive  technique  named  Sur-
face  Wave  Elastometry15,17 attempts  to  assess  biomechanical
properties  by  measuring  the  velocity  of  the  wave  propaga-
tion  along  the  long  axes  of  the  collagen  ﬁbrils.  The  authors
tested,  in  vitro,  the  changes  in  corneal  elasticity  after
CXL  and  found  that  surface  wave  velocity  increased  after
treatment,  thus  assuming  that  the  cornea  was  strengthened
by  increased  stiffness.  Although  using  different  techniques
from  the  one  described  in  our  paper,  the  results  obtained  by
these  non-destructive  techniques  seem  to  concur  with  our
ﬁndings.
In  conclusion,  we  demonstrated  a  signiﬁcant  increase  in
the  mechanical  rigidity  of  human  corneas  after  CXL,  pro-
viding  further  evidence  of  the  effect  of  riboﬂavin/UVA  on
corneal  tissue.  We  have  developed  novel  equipment,  which
we  named  the  Corneal  Displacement  Unit,  to  quantify  the
mechanical  strength  of  whole  corneal  buttons  ex  vivo  with
minimal  damage  to  the  tissue.  This  new  device  could  be
helpful  in  comparing  different  CXL  protocols,  new  riboﬂavin
formulations  and  delivery  methods  of  cross-linking  com-
ponents.  We  believe  this  and  other  related  devices  could
further  expand  our  knowledge  within  this  developing  ﬁeld
of  cross-linking.
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